의생명과학과

I am currently serving as the CEO of Seeders Agricultural Corporation Ltd. and engaging in various research and evaluation organizations, including a position as a visiting researcher at the Korea Institute of Biotechnology, and an expert in technology level assessment at the Ministry of Science and ICT. My research focuses on understanding the genetic diversity of plants and leveraging this knowledge to enhance agricultural productivity.
 
I earned my Ph.D. from the UST (University of Science and Technology), majoring in Functional Genomics and Plant Genomics, with my dissertation titled "Structure of the Tomato Chromosome 2 and Evolution of the 18S-25S Intergenic Spacer Sequence in the Solanaceae". Since then, I have continued my research in the development and improvement of plant genetic resources.

Academically, I have contributed to the advancement of plant genomics through numerous papers and patents. Notably, my research on "Selection of Tomato Tag-SNP representing gene unit haplotype and construction of a web database" and "Improving the accuracy of calculating the recovery rate of heterozygosity based on GBS through chromosome schematization and imputation" has introduced new approaches to plant genetics research. Moreover, patents such as "A set of Single Nucleotide Polymorphism (SNP) markers for scanning the genotype composition of perilla by chromosome and its usage" have significantly enhanced the efficiency of plant breeding research.
 
My career and research are driven by a deep passion for contributing to sustainable agricultural development through a comprehensive understanding of plant genetics. By integrating academic knowledge with practical application research, I aim to contribute to the advancement of future plant genomics science.

Dr. Sungsil Moon is an adjunct professor in the Department of Medical and Biological Sciences at the Catholic University of Korea. She received her Ph.D. in Microbiology and Immunology from the College of Medicine at Korea University. Since 2007, she completed a postdoctoral fellowship, Associate Service Fellow, at the Centers for Disease Control and Prevention (CDC) in the United States, and currently works as a Senior Microbiologist there.
Her primary research focuses on developing vaccines against rotavirus, a leading cause of diarrheal deaths in children under five years old. Specifically, she is conducting preclinical and clinical studies on rotavirus inactivated vaccine and microneedle vaccines for this project.
Dr. Moon serves as an editorial board member for the Journal of Bacteriology and Virology. She is also a member of the American Society for Virology (ASV), the Korean Scientists and Engineers Association in America (KSEA), and the vice president of the Korean-American Women in Science and Engineering (KWiSE), which supports the next generation of women in science and technology. Additionally, she actively engages in science communication through writing columns and publications.

Professor Jihoon Ahn is an adjunct professor in the Department of Medical and Biological Sciences at Catholic University of Koea.

He received a bachelor's degree in economics from Pusan National University, a master's degree in human resource management from Korea University, and Ph.D. Candidate in Management of Science and Technology at Korea University. After working at Samsung and a management consulting firm, he worked as a director of strategic planning at the Samkwang Medical Laboratories. Afterwards, he worked as CEO of SML Genetree Co., Ltd. and Samkwang Labtree Co., Ltd. in the Samkwang Biotree Group, and as auditor of SM L Biopharm Co., Ltd.

His main interests include science and technology policy, technology management, philosophy of science, artificial intelligence ethics, labor distribution between humans and artificial intelligence, development of diagnostic technology using bioinformatics, development of RNA-based therapeutics, research organization development, and technology commercialization in the field of scientific studies. etc.

Currently, he works as Chief Strategy Officer(CSO) of Cytogen Co., Ltd., a company developing diagnostic and therapeutic solutions based on circulating tumor cells(CTC), and Vice President of the Alumni Association of HPM, Seoul National University Graduate School of Public Health. His major awards include the Korea University President's Award in 2017 and the Minister of Commerce, Industry and Energy's Award in 2022.

With multidisciplinary experience, he has served as an adjunct professor of pharmaceutical industry at Ewha Womans University (new drug development/bio/health), adjunct professor of medicine at Konkuk University (full term/clinical/medical science), and outpatient professor of health care management at Woosong University (wellness) at Woosong University.
Since 1989, he has been working as a full-time director of the Korea New Drug Development Research Association as the center of laying the foundation for research and development of new drugs in Korea's biotechnology.It plays a leading role in technology exchange and technology diffusion through the formation of joint R&D partnerships for industry-academia-related diseases at home and abroad, as well as directly participating in policy R&D planning of national R&D projects of various ministries, contributing a lot to promoting Korea's new drug R&D and promoting the bio-health (pharmaceutical/bio) industry at the private level.
More than 40 government (national) technology and policy roadmap planning work related to new drug development and biotechnology have established new drug development and biotechnology as the nation's main key infrastructure industries. The Bioengineering Promotion Act, the Pharmaceutical Industry Development Act, the Natural Products Development Promotion Act, the Global Technology Regulation Research Response, the 1st and 2nd WTO Response Pharmaceutical Industry Development Plan TF participated, Korea/China/Japan/US/EU International cooperation projects, vaccine/rare drug policy research advisory, corporate demand bottom-up research project incubation, private planning and general manager of innovative new drugs/global new drug development. Throughout the development cycle at home and abroad, Presidential Advisory, Medical Industry Advancement Specialist, Ministerial Office Advisory, Pharmaceutical Development Specialist, Investment Review Board, Ministry of Health and Welfare Advisory, Food/Pharmaceutical Safety Technology Deliberation Committee, Food/Central Pharmaceutical Affairs Deliberation Committee, Research Project Management Committee, etc. have contributed to fostering the bio-health industry.

Dr. HAN, Donguk is the adjunct Professor, Department of medical and biological science, The Catholic University of Korea (2022.3. ~ present). He graduated the department of biology and got the Ph. D in the school of life science of Seoul National University.  He works (2019-present) as the director at PGA ecology Institute, ECO KOREA and works (2022-2024) for the ecological society of KOREA and works (2020~2024) for Korean Wetlands Society as the vice president. He worked (2013-2015) as an executive director of bureau of basic ecology at NIE (National Institute of Ecology KOREA).